ES2098921T3 - Composiciones de cetoconazol de uso topico. - Google Patents

Composiciones de cetoconazol de uso topico.

Info

Publication number
ES2098921T3
ES2098921T3 ES94905058T ES94905058T ES2098921T3 ES 2098921 T3 ES2098921 T3 ES 2098921T3 ES 94905058 T ES94905058 T ES 94905058T ES 94905058 T ES94905058 T ES 94905058T ES 2098921 T3 ES2098921 T3 ES 2098921T3
Authority
ES
Spain
Prior art keywords
pct
cetoconazole
compositions
topical use
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94905058T
Other languages
English (en)
Inventor
Marc Karel Josef Francois
Alfons Jeanne Wouters
Gerard Frans Maria Cauwenbergh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2098921T3 publication Critical patent/ES2098921T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A COMPOSICIONES TOPICAS QUE CONTIENEN CETOCONAZOL, UNA ACETONIDA GLUCORTICOSTEROIDE Y UN PORTADOR ACEPTABLE DERMATOLOGICAMENTE CARACTERIZADO POR UN PH POR ENCIMA DE 2.5 Y POR DEBAJO DE 6, Y A UN METODO DE PREPARACION DE DICHA COMPOSICION.
ES94905058T 1993-01-21 1994-01-12 Composiciones de cetoconazol de uso topico. Expired - Lifetime ES2098921T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93200145 1993-01-21

Publications (1)

Publication Number Publication Date
ES2098921T3 true ES2098921T3 (es) 1997-05-01

Family

ID=8213579

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94905058T Expired - Lifetime ES2098921T3 (es) 1993-01-21 1994-01-12 Composiciones de cetoconazol de uso topico.

Country Status (19)

Country Link
US (1) US5654293A (es)
EP (1) EP0680328B1 (es)
JP (1) JP3918119B2 (es)
KR (1) KR100300525B1 (es)
CN (1) CN1096860C (es)
AT (1) ATE146965T1 (es)
AU (1) AU683865B2 (es)
CA (1) CA2153681C (es)
CY (1) CY2106B1 (es)
DE (1) DE69401336T2 (es)
DK (1) DK0680328T3 (es)
ES (1) ES2098921T3 (es)
FI (1) FI114009B (es)
GR (1) GR3022212T3 (es)
HK (1) HK1005999A1 (es)
HU (1) HU221319B1 (es)
NZ (1) NZ259866A (es)
RU (1) RU2126256C1 (es)
WO (1) WO1994016710A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721212B1 (fr) * 1994-06-17 1996-09-13 Pf Medicament Composition et procédé d'obtention d'une émulsion de désonide.
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
FR2747568B1 (fr) * 1996-04-17 1999-09-17 Oreal Utilisation d'au moins un inhibiteur de lipoxygenase et d'au moins un inhibiteur de cyclo-oxygenase pour modifier la pousse des poils et/ou des cheveux
EP0872229A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Compositions containing an antifungal and a phospholipid
PT1024814E (pt) * 1997-10-22 2007-11-29 Mayo Foundation Utilização de agentes antifúngicos para o tratamento tópico de mucosite induzida por fungo
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
GB9915625D0 (en) 1999-07-02 1999-09-01 Cortendo Ab Method
SE9902675D0 (sv) * 1999-07-12 1999-07-12 Astra Ab Pharmaceutical formulations, doses & regimens
GB2365770B (en) * 2000-08-18 2002-07-31 Diomed Dev Ltd Antifungal ketoconazole composition for topical use
WO2004037197A2 (en) * 2002-10-24 2004-05-06 Goldstein Jay A Antifungal formulations
DE102004014617A1 (de) * 2004-03-22 2005-10-13 Beiersdorf Ag Kosmetisches Produkt, umfassend eine thixotropiearme Öl-in-Wasser-Emulsion und einen transparenten Behälter
MXPA06013168A (es) * 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
DE102004032837A1 (de) * 2004-07-02 2006-02-09 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
CN100418530C (zh) * 2005-04-06 2008-09-17 河南省眼科研究所 一种酮康唑滴眼液及其制造方法
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
CA2840215A1 (en) 2011-06-22 2012-12-27 Abhijit S. BAPAT Conjugate-based antifungal and antibacterial prodrugs
US9029342B2 (en) 2012-09-17 2015-05-12 Board Of Regents Of The University Of Texas System Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
BR112015030501A2 (pt) 2013-06-04 2017-07-25 Vyome Biosciences Pvt Ltd partículas revestidas e composições que compreendem as mesmas
BE1022727B1 (nl) * 2015-04-20 2016-08-24 Stasisport Pharma Nv Fusidinezuur crème en methode voor het maken hiervan
CN107260656B (zh) * 2016-04-08 2021-02-09 湖北人福成田药业有限公司 地奈德乳膏及其制备方法
WO2018144841A1 (en) * 2017-02-03 2018-08-09 Board Of Regents, The University Of Texas System Topical voriconazole for the treatment of pain
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
WO1992018133A1 (en) * 1991-04-11 1992-10-29 Drore Eisen Method of treatment using steroid mouthwash

Also Published As

Publication number Publication date
HU221319B1 (en) 2002-09-28
JPH08505861A (ja) 1996-06-25
GR3022212T3 (en) 1997-04-30
WO1994016710A1 (en) 1994-08-04
CY2106B1 (en) 2002-04-26
HUT73233A (en) 1996-07-29
HK1005999A1 (en) 1999-02-05
EP0680328B1 (en) 1997-01-02
CA2153681C (en) 2004-05-25
CN1116824A (zh) 1996-02-14
US5654293A (en) 1997-08-05
JP3918119B2 (ja) 2007-05-23
FI953505A0 (fi) 1995-07-20
AU5883394A (en) 1994-08-15
AU683865B2 (en) 1997-11-27
CA2153681A1 (en) 1994-08-04
EP0680328A1 (en) 1995-11-08
RU2126256C1 (ru) 1999-02-20
HU9501959D0 (en) 1995-09-28
NZ259866A (en) 1999-07-29
DE69401336D1 (de) 1997-02-13
DE69401336T2 (de) 1997-04-24
DK0680328T3 (da) 1997-01-20
FI953505A (fi) 1995-07-20
CN1096860C (zh) 2002-12-25
ATE146965T1 (de) 1997-01-15
FI114009B (fi) 2004-07-30
KR100300525B1 (ko) 2001-10-22

Similar Documents

Publication Publication Date Title
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
ES2137549T3 (es) Derivados antifungicos de sordaridina.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
DE69418461D1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69302677D1 (de) Liposomale piroxycam formulierung
AR000813A1 (es) Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas
KR950700234A (ko) β-페닐이소세린 및 그외 동족체를 제조하는 방법(Method for preparing β-phenylisoserine and analogues thereof)
BR9709393A (pt) Derivados de n-bis ou n-tris-[(1,2-dicarbóxietóxi)etil] amina e preparação e uso dos mesmos
DK0751764T3 (da) Præparat indeholdende retinal
DE69228814D1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ES2144768T3 (es) Derivados de bases esfingoides basados en retinoil-amida.
NO951657L (no) Nöytral selvglansemulsjon for pleie av gulv (III)
BG102213A (en) Endoparasiticidic composition based on didepsipeptides, new didepsipeptides and method for their preparation
ES2118255T3 (es) Agente para uso como antiirritante.
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
IT1275436B (it) Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
DE69712868D1 (de) Biphenylverbindungen sowie ihre anwendung als östrogene mittel
MX9307736A (es) Nuevas triazoloquinazolinas, su obtencion y uso.
ATE293605T1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680328

Country of ref document: ES